Table 5.
Univariate analysis comparing ICU survivors and non-survivors
| n | Deceased (16) | Survived (15) | p |
|---|---|---|---|
| Age, years |
69,5 [29–86] |
57 [32–78] |
0,04 |
| Sex ratio, m/f |
12/4 |
9/6 |
0,45 |
| BVAS |
24.5 [12.0-52.0] |
21.0 [2.0-28.0 ] |
0,06 |
| SAPS II |
46.5 [21.0-109.0] |
35.0 [13.0- 51.0] |
0,004 |
| Mechanical Ventilation, n (%) |
15 (94%) |
10 (67%) |
0.08 |
| SOFA |
7.0 [2.0-15.0] |
3.5 [1.0-10.0] |
0.006 |
| VAP, n (%) |
10 (62.5%) |
10 (66.7%) |
0.80 |
| Vasopressive agents, n (%) |
13 (81,3%) |
5 (33,3%) |
0.006 |
| ARDS, n (%) |
13 (81,3%) |
4 (26,7%) |
0.002 |
| RRT, n (%) |
13 (81,3%) |
5 (33,3%) |
0.007 |
| Creatininemia, microm/l | 297 [56–1067.0] | 76 [32–449] | 0.062 |
Data are presented as median (range) or No/total patients.
BVAS Birmingham Vasculitis Activity Score, SAPSII simplified acute physiology score II, SOFA sequential organ failure assessment, VAP ventilator associated pneumonia, ARDS acute respiratory distress syndrome, RRT renal replacement therapy.